[
    [
        {
            "time": "",
            "original_text": "【国金研究】生物制品行业2018年报2019一季报总结及批签发分析",
            "features": {
                "keywords": [
                    "生物制品",
                    "2018年报",
                    "2019一季报",
                    "批签发"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国金研究】生物制品行业2018年报2019一季报总结及批签发分析",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "【医药】2018年报及2019年一季报综述:轻装上阵、2019有望前低后高、重视商业板块*强于大市",
            "features": {
                "keywords": [
                    "医药",
                    "2018年报",
                    "2019一季报",
                    "轻装上阵",
                    "前低后高",
                    "商业板块"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "商业板块"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】2018年报及2019年一季报综述:轻装上阵、2019有望前低后高、重视商业板块*强于大市",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]